Shire Urges Fed. Circ. To Block Actavis' Generic Lialda
Shire PLC on Wednesday pressed the Federal Circuit to affirm the validity of a patent covering inflammatory bowel disease drug Lialda and declare that Actavis Inc. committed infringement in trying to...To view the full article, register now.
Already a subscriber? Click here to view full article